Chemotargets
Scott Boyer is currently the Chief Executive Officer at Chemotargets SL since October 2020. Scott also serves as the Chief Scientific Advisor at Klaria Pharma AB since January 2015. With previous experience at companies like Swetox and AstraZeneca, Scott has held various high-level positions in the fields of Computational Toxicology and Molecular Toxicology. Additionally, Scott has a strong educational background with a Ph.D. in Molecular Toxicology from the University of Colorado Boulder.
This person is not in any teams
This person is not in any offices
Chemotargets
Chemotargets offers validated and cutting-edge computational methodologies with top market predictive performance. The innovation strategy of the company is driven by new computational methods and strategies directed by Dr. Mestres. Chemotargets’ goal is to help the biopharma industry fast-forward the process of bringing new medicines to market, speeding up drug discovery and development programs, and improving cost-efficiency and safety.